Vimentin (3CB2) Antibody sc-80975 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemVimentin (3CB2) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price Pricing Info Supplier Page View Company Product Page
Catalog Numbersc-80975
Antibody TypePrimary Antibodies
Quantity200 µg/ml
Clone3CB2
ApplicationsWB, IP, IF, IHC(P)
Reactivitychicken, human, mouse, rat
Hostmouse
Conjugate/TagUnconjugated
FormatPurified
ClonalityMonoclonal
NCBI Full Gene Namevimentin
TargetVimentin
IsotypeIgM

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for GlioblastomaBiomedicinesNovember 28, 2023Hyukjun Kwon, Minji Yun, Taek-Hyun Kwon, Minji Bang, Jungsul Lee, Yeo Song Lee, Hae Young Ko, Kyuha ChongSurvivin (1:1000 v/v; Catalog No. ab76424; Abcam, Cambridge, UK), Vimentin (1:1000 v/v; Catalog No. sc-80975; Santa-Cruz, Dallas, TX, USA), Twist (1:1000 v/v; Catalog No. ab50887; Abcam), Nestin (1:500 v/v; Catalog

(2) Prospective Application of Partially Digested Autologous Chondrocyte for Meniscus Tissue EngineeringPharmaceuticsMarch 10, 2022Piya-on Numpaisal, Ching-Chuan Jiang, Chang-Hsun Hsieh, Hongsen Chiang, Chung-Liang ChienGeneTex, Irvine, CA, USA (Cat. No. GTX20300); 4 Santa Cruz Biotechnology, Dallas, TX, USA (Cat. No. sc-80975); 5 Sigma-Aldrich, Saint Louis, MO, USA (Cat. No. F9887/T5393); 6 Sigma-Aldrich, Saint Louis, MO, USA

(3) NF-κB–Dependent Snail Expression Promotes Epithelial–Mesenchymal Transition in MastitisAnimals (Basel)December 1, 2021Haokun Liu, Ying Zhao, Yanfang Wu, Yutong Yan, Xiaoe Zhao, Qiang Wei, Baohua Ma1:100 for IF N-cadherin,abcam,ab76057,1:2000 for WBor 1:100 for IF Vimentin,Santa Cruz Biotechnology,sc-80975,1:1000 for WBor 1:100 for IF α-SMA,Santa Cruz Biotechnology,sc-56499,1:1000 for WB Collagen III,Santa Cruz Biotechnology

(4) Intrahepatic Cholangiocarcinoma Cells Promote Epithelial-mesenchymal Transition of Hepatocellular Carcinoma Cells by Secreting LAMC2Journal of CancerApril 19, 2021Wenda Cen, Jiandong Li, Chenhao Tong, Weiguang Zhang, Yunfeng Zhao, Baochun Lu, Jianhua YuMI, USA). Antibodies against β-actin (sc‑47778), LAMC2 (sc‑28330), E-cadherin (sc‑71009), Vimentin (sc‑80975) and Snail (sc‑271977) were purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA). Cell culture The

(5) Long non-coding RNA LSINCT5 inactivates Wnt/β-catenin pathway to regulate MCF-7 cell proliferation and motility through targeting the miR-30aAnnals of Translational MedicineJanuary 25, 2021Guizhi Zhang, Wenbo SongUSA), caspase-3 (sc-271759, 1:1,000, SCB, USA), E-cadherin (sc-8426, 1:1,000, SCB, USA), Vimentin (sc-80975, 1:1,000, SCB, USA), N-cadherin (sc-8424, 1:1,000, SCB, USA), β-catenin (#2698, 1:1,000, Cell Signaling Technology

(6) Forskolin promotes vasculogenic mimicry and invasion via Notch‑1‑activated epithelial‑to‑mesenchymal transition in syncytiolization of trophoblast cells in choriocarcinomaInternational Journal of OncologyFebruary 20, 2020Yan Xue, Rong Sun, Wei Zheng, Lei Yang, Ruifang Ancyto-keratin (CK19; cat. no. sc376126; Santa Cruz Biotechnology, Inc.; 1:1,000), vimentin (cat. no. sc80975; Santa Cruz Biotechnology, Inc.; 1:400) and MMP-9 (cat. no. sc10737; Santa Cruz Biotechnology, Inc.;

(7) Trichostatin A reverses epithelial‑mesenchymal transition and attenuates invasion and migration in MCF‑7 breast cancer cellsExperimental and Therapeutic MedicineJanuary 3, 2020Xiaoxiong Wang et al.E-cadherin (1:1,000; cat. no., sc-71008; Santa Cruz Biotechnology, Inc.), vimentin (1:1,000; cat. no., sc-80975; Santa Cruz Biotechnology, Inc.), SLUG (1:1,000; cat. no., sc-166476; Santa Cruz Biotechnology, Inc.)

(8) The SIRT2-mediated deacetylation of AKR1C1 is required for suppressing its pro-metastasis function in Non-Small Cell Lung CancerTheranosticsJanuary 1, 2020Zhu H, Hu Y, Zeng C, Chang L, Ge F, Wang W, Yan F, Zhao Q, Cao J, Ying M, et al.(Santa Cruz, sc-58666), Flag (Genescript, A00187-100), Sox2 (Santa Cruz, sc-365964), Vimentin (Santa Cruz, sc-80975). In Vitro Deacetylation Assay 293FT cells were transfected with HA-tagged AKR1C1 (treated with TSA

(9) Long noncoding RNA LINC01111 suppresses pancreatic cancer aggressiveness by regulating DUSP1 expression via microRNA-3924Cell death & diseaseNovember 25, 2019Pan S, Shen M, Zhou M, Shi X, He R, Yin T, Wang M, Guo X, Qin R.(Chicago, IL, USA); anti-PCNA (sc-25280), anti-Ki-67 (sc-15402), anti-N-cadherin (sc-53488), anti-Vimentin (sc-80975) antibody were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA); SAPK/JNK signaling pathway

(10) CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinomaOncology reportsAugust 1, 2019Li S, Chai Y, Ding Y, Yuan T, Wu C, Huang C.sc-53488), anti-E-cadherin (dilution 1:500; cat. no. sc-71008), anti-vimentin (dilution 1:600; cat. no. sc-80975), anti-p53 (dilution 1:600; cat. no. sc-47698), anti-cyclin D1 (dilution 1:750; cat. no. sc-8396) and

(11) TIGAR promotes growth, survival and metastasis through oxidation resistance and AKT activation in glioblastomaOncology LettersJuly 5, 2019Zhi Tang, Zhengwen Hesc-59987; 1:1,000 dilution), anti-Snail (cat. no. sc-271977; 1:1,000 dilution), anti-Vimentin (cat. no. sc-80975; 1:1,000 dilution) and HRP-conjugated goat anti-mouse IgG (m-IgGκ BP-HRP; cat. no. sc-516102; 1:4,000

(12) miR‑27a suppresses TLR4‑induced renal ischemia‑reperfusion injuryMolecular Medicine ReportsJune 4, 2019Yang Wang, Dan Wang, Zhen Jincat. no. sc-20067), E-cadherin (E-cad, 1:1,000; cat. no. sc-71009), Vimentin (vim, 1:1,000; cat. no. sc-80975) and GAPDH (1:1,000; cat. no. sc-51907), all purchased from Santa Cruz Biotechnology Inc. (Dallas, TX,

(13) The HBx-CTTN interaction promotes cell proliferation and migration of hepatocellular carcinoma via CREB1Cell death & diseaseMay 28, 2019Li Y, Fu Y, Hu X, Sun L, Tang D, Li N, Peng F, Fan XG.et al. Cell Death and Disease (2019)10:405 20874, Proteintech), and anti-vimentin (dilution 1:1000, sc-80975, Santa Cruz). After incubating with goat antimouse and goat anti-rabbit secondary antibodies for 1 h

(14) The inhibitive effect of sh-HIF1A-AS2 on the proliferation, invasion, and pathological damage of breast cancer via targeting miR-548c-3p through regulating HIF-1α/VEGF pathway in vitro and vivoOncoTargets and TherapyFebruary 19, 2019Xiao Guo, Shenghai Lee, Peilong Cao1:1,000), VEGF (sc-7269, 1:1,000), PCNA (sc-71858, 1:1,000), E-cadherin (sc-8426, 1:1,000), vimentin (sc-80975, 1:1,000), N-cadherin (sc-8424, 1:1,000), HIF-1α (sc-13515, 1:1,000), and GAPDH (sc-66163, 1:1,000)

(15) ZEB1 promotes tumorigenesis and metastasis in hepatocellular carcinoma by regulating the expression of vimentinMolecular Medicine ReportsJanuary 15, 2019Yue Qin, Jingxi Yu, Ming Zhang, Faxiang Qin, Xiong Lanantibody (cat. no. ab180905; 1:150 dilution; Abcam, Cambridge, MA, USA) or anti‑VIM antibody (cat. no. sc‑80975; 1:50 dilution; Santa Cruz Biotechnology, Inc., TX, USA) at 4˚C overnight and washed with phosphate‑buffered

(16) KIAA0101 is a novel transcriptional target of FoxM1 and is involved in the regulation of hepatocellular carcinoma microvascular invasion by regulating epithelial-mesenchymal transitionJournal of CancerJanuary 1, 2019Zhang T, Guo J, Gu J, Chen K, Wang Z, Li H, Wang G, Wang J.E-cadherin (1:500; cat. no. sc-71007), N-cadherin (1:1000; cat. no. sc-59987), and vimentin (1:500; cat. no. sc-80975) were purchased from Santa Cruz (Santa Cruz, CA, USA); SNAIL (1:1000; cat. no. # 3879T) was purchased

(17) The SOX2OT/miR‑194‑5p axis regulates cell proliferation and mobility of gastric cancer through suppressing epithelial‑mesenchymal transitionOncology LettersSeptember 12, 2018Ruqiong Wei, Can Ding, Raquel Alarcòn Rodr�guez, Mar�a Del Mar Requena Mullorprimary antibodies as follows: anti‑E‑cadherin (sc‑71007), anti‑N‑cadherin (sc‑59987), anti‑Vimentin (sc‑80975), anti‑MMP‑2 (sc‑13594), anti‑MMP‑9 (sc‑13520) and anti‑GAPDH (sc‑32233) (at a dilution 1:1,000; Santa Cruz Biotechnology, Inc

(18) GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activationOncology ReportsJuly 20, 2018Bing Ji, Yifei Feng, Ye Sun, Dongjian Ji, Wenwei Qian, Zhiyuan Zhang, Qingyuan Wang, Yue Zhang, Chuan Zhang, Yueming Sunincluded were as follows: GPR56 (cat. no. sc-390192), E-cadherin (cat. no. sc-71009), vimentin (cat. no. sc-80975), PI3K (cat. no. sc-293172), AKT (cat. no. sc-135829) and GAPDH (cat. no. sc-47724). These antibodies

(19) NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the Akt/Stat3 signaling pathwayOncology ReportsJuly 13, 2018Chuanqing Wu, Xiaojie Zhu, Weizhen Liu, Tuo Ruan, Wenze Wan, Kaixiong Taosc‑71009), N‑cadherin (dilution 1:1,000; cat. no. sc‑59987) and vimentin (dilution 1:1,000; cat. no. sc‑80975) were purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA). Akt/p‑Akt (dilution 1:1,000;

(20) Mn12Ac inhibits the migration, invasion and epithelial‑mesenchymal transition of lung cancer cells by downregulating the Wnt/β‑catenin and PI3K/AKT signaling pathwaysOncology LettersJuly 11, 2018Zihao Chen et al.Santa Cruz Biotechnology, Inc.), N‑cadherin (1:1,000; sc‑59987; Santa Cruz Biotechnology, Inc.), vimentin (1:1,000; sc‑80975; Santa Cruz Biotechnology, Inc.), Wnt1 (1:1,000; sc‑6266; Santa Cruz Biotechnology, Inc.), β‑catenin (1:1,000;

Be the First to Write a Review!

Vimentin (3CB2) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (25)

Reviews

Vimentin (3CB2) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map